Xingmei Zhang

Xingmei Zhang

Company: Hansa Biopharma

Job title: Franchise Program Lead


IgG Cleaving Enzymes as a Potential Solution to the NAb Challenge 11:45 am

An overview of IgG cleaving enzymes: their MOA and translatability for use in conjunction with gene therapies Discussing clinical data from non-gene therapy indications Considerations for treatment timing and dosing of gene therapy post-administration of enzymeRead more

day: Day 2 CLINICAL AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.